$INO 8-K SEC Filings

Filed On	Filing
06 Oct 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year This Amendment (the “Amendment”) to the Amended and Restated Bylaws (the “Bylaws”) of Inovio Pharmaceuticals, Inc., a Delaware corporation (the “Corporation”), is made effective as of the date first above written in accordance with Artic...
12 Aug 2026	8-K: Results of Operations and Financial Condition
31 Jul 2026	8-K: Entry into a Material Definitive Agreement; Other Events
29 Jul 2026	8-K: Results of Operations and Financial Condition
20 May 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
13 May 2026	8-K: Results of Operations and Financial Condition
06 Apr 2026	8-K: Entry into a Material Definitive Agreement; Other Events
02 Apr 2026	8-K: Other Events
12 Mar 2026	8-K: Results of Operations and Financial Condition
27 Jan 2026	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders
29 Dec 2025	8-K: Regulation FD Disclosure; Other Events
12 Nov 2025	8-K: Entry into a Material Definitive Agreement; Other Events
10 Nov 2025	8-K: Results of Operations and Financial Condition
12 Aug 2025	8-K: Results of Operations and Financial Condition
07 Jul 2025	8-K: Entry into a Material Definitive Agreement; Other Events
22 May 2025	8-K: Submission of Matters to a Vote of Security Holders
13 May 2025	8-K: Results of Operations and Financial Condition
18 Mar 2025	8-K: Results of Operations and Financial Condition
16 Dec 2024	8-K: Entry into a Material Definitive Agreement; Other Events
14 Nov 2024	8-K: Results of Operations and Financial Condition

Comments